Protease enzymes cut other proteins into pieces, but some can be blocked by inhibitors. One such inhibitor binds to the substrate rather than the enzyme, suggesting a new tactic for drug discovery.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kukar, T. L. et al. Nature 453, 925–929 (2008).
Flexner, C. N. Engl. J. Med. 338, 1281–1292 (1998).
Rich, J. B. et al. Neurology 45, 51–55 (1995).
Beher, D. et al. J. Biol. Chem. 279, 43419–43426 (2004).
Dong, D. L., Liu, R., Sherlock, R., Wigler, M. H. & Nestler, H. P. Chem. Biol. 6, 133–141 (1999).
Zhang, Z., Ly, T. & Kodadek, T. Chem. Biol. 8, 391–397 (2001).
Kodadek, T. Biopolym. Peptide Sci. 66, 134–140 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kodadek, T. Molecular cloaking devices. Nature 453, 861–862 (2008). https://doi.org/10.1038/453861a
Published:
Issue Date:
DOI: https://doi.org/10.1038/453861a
This article is cited by
-
Novel route to protease targeting
Nature Reviews Drug Discovery (2008)
